Pharma shells out $100B on M&A in 2018 so far, with more to come: report
admin 6th July 2018 Uncategorised 0After an unusually slow 2017, deal-making in Big Pharma roared back to life in the first half of this year. With such names as Johnson & Johnson and Allergan mulling both acquisitions and selloffs of some of their core assets, the M&A boom will likely continue through 2018.
More: Pharma shells out 0B on M&A in 2018 so far, with more to come: report
Source: fierce